FIGO Grade 1 Endometrioid Adenocarcinoma

FIGO Grade 1 Endometrioid Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04604613	Prediction of Recurrence Among Low Risk Endometrial Cancer Patients	active not recruiting	—	518	M.D. Anderson Cancer CenterOTHER	1	Sep 16, 2026	clinicaltrials
NCT02397083	Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer(LEVER)	active not recruiting	Phase 2	102	M.D. Anderson Cancer CenterOTHER	1